Rest Of Europe Autoimmunity Diagnostics Market (2025-2030)
The Rest Of Europe Autoimmunity Diagnostics Market was valued at $255.8 Million in 2025 and projected to reach to $445.5 Million by 2030, representing a compound annual growth rate of 9.7%. Rest Of Europe's autoimmunity diagnostics market is positioned for sustained growth through 2030, driven by increasing prevalence of autoimmune disorders, rising healthcare spending, and expanding access to diagnostic infrastructure across the region.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe Autoimmunity Diagnostics Market Trends and Insights
- Rest Of Europe demonstrates a compound annual growth rate of 9.7%, outpacing global trends and reflecting strong regional demand for advanced diagnostic solutions.
- This growth trajectory in Rest Of Europe is driven by increasing prevalence of autoimmune disorders, rising healthcare expenditure, and expanding adoption of multiplex testing platforms across secondary and tertiary care facilities. Rest Of Europe's market expansion is supported by favorable regulatory environments, growing laboratory automation, and heightened awareness among healthcare providers regarding early disease detection.
- The region's diverse healthcare infrastructure creates varied adoption patterns, with Rest Of Europe showing particular strength in countries with established diagnostic networks and reimbursement frameworks.
- Between 2025 and 2030, Rest Of Europe is expected to capture significant market share through investments in point-of-care testing and immunoassay innovations, positioning the region as a key growth engine within the broader European autoimmunity diagnostics landscape..
Key Market Statistics
- CAGR (2025-2030) 9.7% CAGR
- Market Size, 2025 ~USD 255.8 Million
- Forecast, 2030 ~USD 445.5 Million
- Country Rest Of Europe
Rest Of Europe Autoimmunity Diagnostics Market Overview
Strong Regional Growth :
Rest Of Europe's autoimmunity diagnostics market is expanding at 9.7% CAGR, significantly outpacing the global average of 8.3%, indicating robust regional demand and market maturation.
Substantial Market Valuation :
The market is valued at USD 255.8 million in 2025 with a projected valuation of USD 445.5 million by 2030, representing a 74% increase over the five-year forecast period.
Advanced Diagnostic Adoption :
Rest Of Europe demonstrates strong adoption of advanced autoimmunity diagnostic solutions, driven by healthcare infrastructure development and increasing clinical awareness across secondary and tertiary care centers.
Regional Healthcare Investment :
Growing healthcare expenditure and regulatory support for diagnostic innovation in Rest Of Europe countries are accelerating market penetration and creating opportunities for diagnostic technology providers.
Rest Of Europe Autoimmunity Diagnostics Market Dynamics
- The 9.7% CAGR reflects strong demand for both conventional and advanced diagnostic modalities, including multiplex assays and point-of-care testing solutions. Key growth drivers include aging populations, improved disease awareness among healthcare professionals, and regulatory harmonization efforts facilitating market entry.
- Investment in laboratory automation and digital health integration will further enhance diagnostic capabilities.
- Rest Of Europe's market trajectory suggests increasing consolidation among diagnostic providers and growing partnerships with healthcare systems to expand service offerings and geographic reach..
Related Ecosystem
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Merck KGaA
- Shimadzu Corporation
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Rest Of Europe's autoimmunity diagnostics market will grow from USD 255.8M (2025) to USD 445.5M (2030) at a 9.7% CAGR, significantly outpacing global growth rates.
- Rest Of Europe is driven by rising autoimmune disease prevalence, increased healthcare spending, and adoption of advanced multiplex diagnostic platforms.
- Rest Of Europe benefits from favorable regulatory frameworks and laboratory automation investments that enhance diagnostic accessibility and accuracy.
- Rest Of Europe's diverse healthcare infrastructure creates differentiated growth opportunities, with strongest momentum in countries with established reimbursement systems.
Autoimmunity Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | AUTOANTIBODIES AND IMMUNOLOGIC TESTS (Test Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 8.3% from 2025 to 2030 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 5.57 (2025) |
| Revenue Forecast (Billions) | ~USD 8.29 (2030) |
| Segments Covered | Product, Test Type, Disease Type, Type, End User |
Rest Of Europe Autoimmunity Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Test Type
- Autoantibodies And Immunologic Tests
- Inflammatory Tests
- Other Tests
- Routine Laboratory Tests
- Urinalysis Tests
By Disease Type
- Organ-Specific Autoimmune Diseases
- Systemic Autoimmune Diseases
By Type
- Celiac Disease
- Inflammatory Bowel Disease
- Multiple Sclerosis
- Other Organ-Specific Autoimmune Diseases
- Other Systemic Autoimmune Diseases
- Psoriasis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Type-1 Diabetes
By End User
- Clinical Laboratories
- Hospitals & Clinics
- Other End Users
Target Audience
- Diagnostic Device Manufacturers : Need Rest Of Europe-specific market data to develop regional product strategies, identify unmet diagnostic needs, and prioritize market entry or expansion investments in high-growth European territories.
- Healthcare System Administrators : Require market insights to optimize diagnostic service procurement, evaluate emerging technologies, and plan laboratory infrastructure investments aligned with regional demand trends.
- Clinical Laboratory Operators : Seek detailed market analysis to benchmark performance, identify growth opportunities in autoimmunity testing, and make informed decisions on technology adoption and service expansion.
- Investment & Private Equity Firms : Need comprehensive Rest Of Europe market data to evaluate investment opportunities in diagnostic companies, assess market attractiveness, and support due diligence for acquisition targets.
- Healthcare Consultants & Advisors : Require region-specific market intelligence to support client strategy development, competitive analysis, and market entry planning for autoimmunity diagnostics in Rest Of Europe.
Reasons to Buy this Report
- Regional Market Sizing & Forecasting : Obtain precise market valuation data specific to Rest Of Europe (USD 255.8M in 2025), enabling accurate budget allocation and revenue projections for regional expansion strategies.
- Competitive Landscape Intelligence : Understand Rest Of Europe's competitive dynamics, key players, and market positioning to identify partnership opportunities and differentiation strategies within this high-growth region.
- Growth Driver Analysis : Identify region-specific factors driving the 9.7% CAGR, including regulatory environment, healthcare infrastructure, and disease prevalence patterns unique to Rest Of Europe markets.
- Investment Decision Support : Make informed capital allocation decisions with comprehensive Rest Of Europe market data, supporting business case development for market entry, expansion, or M&A activities.
- Strategic Market Positioning : Benchmark Rest Of Europe performance against global trends (8.3% CAGR) to identify regional opportunities and tailor product development, pricing, and go-to-market strategies accordingly.
Frequently asked questions
What is the market size of autoimmunity diagnostics in Rest Of Europe in 2025?
Rest Of Europe's autoimmunity diagnostics market is valued at USD 255.8 million in 2025, representing a significant segment within the broader European diagnostic landscape.
What is the projected market size for Rest Of Europe by 2030?
Rest Of Europe's autoimmunity diagnostics market is forecast to reach USD 445.5 million by 2030, reflecting sustained expansion over the five-year period.
What is the CAGR for Rest Of Europe's autoimmunity diagnostics market?
Rest Of Europe demonstrates a compound annual growth rate of 9.7% from 2025 to 2030, outperforming the global average of 8.3%.
What factors are driving growth in Rest Of Europe's autoimmunity diagnostics market?
Rest Of Europe's growth is driven by increasing autoimmune disease prevalence, rising healthcare expenditure, laboratory automation, favorable regulatory environments, and expanding adoption of multiplex testing platforms.
Which countries within Rest Of Europe show the strongest market potential?
Rest Of Europe shows strongest momentum in countries with established diagnostic networks, robust reimbursement frameworks, and significant healthcare infrastructure investments in secondary and tertiary care facilities.
RESEARCH METHODOLOGY
The study involved estimating activities to determine the current size of the autoimmunity diagnostics market. Exhaustive secondary research was done to collect information on the autoimmunity diagnostics industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the autoimmunity diagnostics market.
Secondary Research
Various sources were utilized to gather information for this study in the secondary research process. These sources included company annual reports, press releases, and investor presentations; white papers; certified publications; articles by recognized authors; reputable websites; and information from regulatory bodies and databases, such as D&B Hoovers, Bloomberg Business, and Factiva.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott Laboratories (US) | Product Specialist |
| Thermo Fisher Scientific Inc. (US) | Clinical Sales Specialist |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the autoimmunity diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry were identified through extensive secondary research.
- Primary and secondary research determined the revenues generated by leading players operating in the autoimmunity diagnostics market.
- All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments after arriving at the overall market size by applying the abovementioned process. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Autoimmune diseases are defined as a medical condition in which an individual's immune system produces antibodies that attack the body's normal tissues. autoimmunity diagnostics systematically identifies autoimmune disorders through clinical assessment and laboratory investigations to detect immune system dysfunction. This process typically involves routine laboratory testing, measurement of systemic inflammatory markers, detection of disease-specific autoantibodies, urinalysis, and other specialized immunologic assays.
Stakeholders
- Manufacturers & distributors of autoimmunity diagnostics products
- Clinical laboratories
- Hospitals
- Research institutes
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global autoimmunity diagnostics market, by product, test type, disease type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall autoimmunity diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
Get the Full Autoimmunity Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Autoimmunity Diagnostics Market.
- US Autoimmunity Diagnostics Market
- Canada Autoimmunity Diagnostics Market
- UK Autoimmunity Diagnostics Market
- Germany Autoimmunity Diagnostics Market
- France Autoimmunity Diagnostics Market
- Italy Autoimmunity Diagnostics Market
- Spain Autoimmunity Diagnostics Market
- China Autoimmunity Diagnostics Market
- Japan Autoimmunity Diagnostics Market
- India Autoimmunity Diagnostics Market
- Australia Autoimmunity Diagnostics Market
- Rest Of Asia Pacific Autoimmunity Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
